Exploiting different ways to die

Genes and Development

Volumn 18, Issue 11, 2004, Pages 1223-1226

  Nelson, Deirdre A ^a   White, Eileen ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALKYLATING AGENT; DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; AUTOPHAGY; CAENORHABDITIS ELEGANS; CANCER; CANCER CONTROL; CELL DEATH; DNA ALKYLATION; DNA DAMAGE; DROSOPHILA; GENE MUTATION; MAMMAL; NECROSIS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR SUPPRESSOR GENE;

ALKYLATING AGENTS; ANIMALS; APOPTOSIS; AUTOPHAGY; CELL DEATH; DNA; HUMANS; NECROSIS; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; CAENORHABDITIS; CAENORHABDITIS ELEGANS; MAMMALIA;

EID: 2642545898     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1212404     Document Type: Review

References (22)

1. Adams, J.M. 2003. Ways of dying: Multiple pathways to apoptosis. Genes & Dev. 17: 2481-2495.
2. Bruckheimer, E.M., Brisbay, S., Johnson, D.J., Gingrich, J.R., Greenberg, N., and McDonnell, T.J. 2000. Bcl-2 accelerates multistep prostate carcinogenesis in vivo. Oncogene 19: 5251-5258.
3. Cory, S., Huang, D.C., and Adams, J.M. 2003. The Bcl-2 family: Roles in cell survival and oncogenesis. Oncogene 22: 8590-8607.
4. Danial, N.N. and Korsmeyer, S.J. 2004. Cell death: Critical control points. Cell 116: 205-219.
5. Debnath, J., Mills, K.R., Collins, N.L., Reginato, M.J., Muthuswamy, S.K., and Brugge, J.S. 2002. The role of apoptosis in creating and maintaining luminal space within normal nd oncogene-expressing mammary acini. Cell 111: 29-40.
6. Degenhardt, K., Chen, G., Lindsten, T., and White, E. 2002. Bax and Bak mediate p53-independent suppression of tumorigenesis. Cancer Cell 2: 193-203.
7. Gonzalez, V.M., Fuertes, M.A., Alonso, C., and Perez, J.M. 2001. Is cisplatin-induced cell death always produced by apoptosis? Mol. Pharmacol. 59: 657-663.
8. Hager, J.H. and Hanahan, D. 1999. Tumor cells utilize multiple pathways to down-modulate apoptosis. Lessons from a mouse model of islet cell carcinogenesis. Ann. NY Acad. Sci. 887: 150-163.
9. Hanahan, D. and Weinberg, R.A. 2000. The hallmarks of cancer. Cell 100: 57-70.
10. Johnstone, R.W., Ruefli, A., and Lowe, S.W. 2002. Apoptosis: A link between cancer genetics and chemotherapy. Cell 108: 153-164.
11. Klionsky, D.J. and Emr, S.D. 2000. Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721.
12. Levine, B. and Klionsky, D.J. 2004. Development by self-digestion; molecular mechanisms and biological functions of autophagy. Dev. Cell 6: 463-477.
13. Levine, A.J., Perry, M.E., Chang, A., Silver, A., Dittmer, D., Wu, M., and Welsh, D. 1994. The 1993 Walter Hubert lecture: The role of the p53 tumour-suppressor gene in tumorigenesis. Br. J. Cancer 69: 409-416.
14. Liang, X.H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., and Levine, B. 1999. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676.
15. Manion, M.K. and Hockenbery, D.M. 2003. Targeting BCL-2-related proteins in cancer therapy. Cancer Biol. Ther. 2: S105-S114.
16. Mills, K.R., Reginato, M., Debnath, J., Queenan, B., and Brugge, J.S. 2004. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro. Proc. Natl. Acad. Sci. 101: 3438-3443.
17. Pardee, A.B., Li, Y.Z., and Li, C.J. 2002. Cancer therapy with β-lapachone. Curr. Cancer Drug Targets 227: 242.
18. Proskuryakov, S.Y. and Konoplyannikov, A.G. 2003. Necrosis: A specific form of programmed cell death? Exp. Cell Res. 283: 1-16.
19. Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., Rosen, J., Eskelinen, E.L., Mizushima, N., Ohsumi, Y., et al. 2003. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 112: 1809-1820.
20. Takeuchi, H., Kanzawa, T., Kondo, Y., and Kondo, S. 2004. Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells. Br. J. Cancer 90: 1069-1075.
21. Yue, Z., Jin, S., Yang, C., Levine, A.J., and Heintz, N. 2003. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. 100: 15077-15082.
22. Zong, W.-X., Ditsworth, D., Bauer, D.E., Wang, Z.-Q., and Thompson, C.B. 2004. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes & Dev. (this issue).